Duloxetine (brand name Cymbalta) treats five FDA-approved conditions: major depressive disorder, generalized anxiety disorder, diabetic nerve pain, fibromyalgia, and chronic musculoskeletal pain. First approved in 2004, it belongs to a class of medications called SNRIs, which work by increasing levels of two chemical messengers in the brain: serotonin and norepinephrine. This dual action is what makes duloxetine unusually versatile, effective for both mood disorders and physical pain conditions.
How Duloxetine Works
Duloxetine blocks the reabsorption of serotonin and norepinephrine after nerve cells release them. This keeps more of both chemicals active in the brain, which helps regulate mood and amplifies the body’s natural pain-suppressing pathways. The pain relief works through at least two distinct mechanisms, according to research published in the Journal of Neuroscience. One is fast-acting: the brain sends stronger “turn down the pain” signals through the spinal cord. The other is slower and happens at the site of nerve damage itself, where the drug appears to calm inflammatory immune responses that contribute to pain.
This combination of central and peripheral pain relief explains why duloxetine is prescribed for such a wide range of pain conditions, not just mood disorders.
Depression and Anxiety
Duloxetine is approved to treat major depressive disorder in adults and generalized anxiety disorder in both adults and children aged 7 and older. For mood-related conditions, it typically takes 2 to 4 weeks before you notice improvement. Treatment usually starts at a lower dose for the first week before increasing to the target dose, giving your body time to adjust.
One important safety note: antidepressants, including duloxetine, carry an FDA black box warning about an increased risk of suicidal thoughts and behavior in children, adolescents, and young adults under 25. This risk was observed in short-term studies. In adults over 65, antidepressants were actually associated with a reduced risk compared to placebo. Anyone starting duloxetine should be monitored closely in the early weeks, especially for unusual mood changes.
Diabetic Nerve Pain
Duloxetine is one of the first-line treatments for diabetic peripheral neuropathy, the burning, tingling, or shooting pain that develops when high blood sugar damages nerves in the hands and feet. Pain relief for nerve conditions may take longer than 2 to 4 weeks to fully develop, since the delayed anti-inflammatory mechanism at the nerve site needs time to build up.
Fibromyalgia
Fibromyalgia causes widespread pain, fatigue, and tenderness throughout the body. Duloxetine is approved for fibromyalgia in adults and in adolescents aged 13 and older. Because fibromyalgia involves abnormal pain processing in the central nervous system, duloxetine’s ability to strengthen the brain’s descending pain-control signals makes it a logical fit for this condition.
Chronic Musculoskeletal Pain
This includes chronic low back pain and osteoarthritis pain. The standard dose is 60 mg once daily, typically started at 30 mg for one week before increasing. Going above 60 mg does not appear to provide additional pain relief and increases the likelihood of side effects.
The clinical trial results for musculoskeletal pain are a mixed picture. In chronic low back pain, two out of three major trials showed significantly greater pain reduction compared to placebo over 12 to 13 weeks, while one trial found no significant difference. For osteoarthritis, one of two trials showed significant benefit. This means duloxetine clearly helps some people with these conditions, but it is not a guarantee of relief for everyone. Trial durations suggest you should give the medication at least 12 to 13 weeks to assess whether it’s working for pain.
Off-Label Uses
Doctors sometimes prescribe duloxetine for conditions beyond its five FDA-approved uses. The most well-supported off-label use is chemotherapy-induced peripheral neuropathy, the nerve pain that can develop as a side effect of cancer treatment. The American Society of Clinical Oncology includes duloxetine in its guidelines for this condition.
Stress urinary incontinence is another off-label use with supporting evidence. In some countries, duloxetine may be offered as an alternative to surgery for women with this condition. It has also been studied in small trials for PTSD, though evidence remains limited and other medications are preferred as first-line options.
Common Side Effects
Nausea is the most frequently reported side effect, especially in the first week or two. Other common effects include dry mouth, drowsiness, constipation, and decreased appetite. Most of these tend to ease as your body adjusts to the medication. Starting at a lower dose for the first week helps minimize early side effects.
Who Should Not Take Duloxetine
Duloxetine should not be taken alongside a class of older antidepressants called MAOIs. Combining them can trigger a dangerous reaction involving rapid changes in heart rate, blood pressure, body temperature, and mental state. You need to wait at least 14 days after stopping an MAOI before starting duloxetine, and vice versa.
People with liver disease or those who drink heavily should not take duloxetine. Cases of serious liver damage, including liver failure, have been reported. The drug should also be avoided if you have uncontrolled narrow-angle glaucoma, since it can affect pupil dilation and raise eye pressure.
Duloxetine is not something you should stop abruptly. Tapering off gradually under medical guidance helps avoid withdrawal symptoms like dizziness, irritability, and sensations sometimes described as “brain zaps.”